Kato CNAO, Ribeiro MC, Abreu MHNG, Grossmann SMC, Abreu LG, Caldeira PC, et al. What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?. Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25 (4):e468-73.
doi:10.4317/medoral.23448
https://dx.doi.org/doi:10.4317/medoral.23448
1. Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, Rothová A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg. 2016;69:295-304. |
PMid:26723834 |
2. da Silva WB, Ribeiro AL, de Menezes SA, de Jesus Viana Pinheiro J, de Melo Alves-Junior S. Oral capillary hemangioma: A clinical protocol of diagnosis and treatment in adults. Oral Maxillofac Surg. 2013;18:431-7. |
PMid:24263242 |
3. Nishida R, Inoue R, Takimoto Y, Kita T. A sclerosant with astringent properties developed in China for esophageal varices: comparison with ethanolamine oleate and polidocanol. J Gastroenterol Hepatol. 1999;14:481-8. |
PMid:10355514 |
4. Kaji N, Kurita M, Ozaki M, Takushima A, Harii K, Narushima M, et al. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg. 2009;43:126-36. |
PMid:19401940 |
5. Iso MA, Kitano S, Iwanga T, Koyanagi N, Sugimachi K. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices. Endoscopy. 1988;20:285-8. |
PMid:3229387 |
6. Johann ACBR, Aguiar MCF, Carmo MAV, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: An open clinical trial with 30 lesions. Oral Surg Oral Med Oral Radiol. 2005;100:570-84. |
PMid:16243243 |
7. Costa JRS, Torriani MA, Hosni ES, D Ávila OP, Figueiredo PJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg. 2011;69:88-92. |
PMid:21272976 |
8. Hiraoka K, Mota De Queiroz A, Aparecida Marinho S, Costa Pereira AA, Costa Hanemann JA. Sclerotherapy with monoethanolamine oleate in benign oral vascular lesions. Minerva Stomatol. 2012;61:31-6. |
PMid:22274308 |
9. Fernandes DT, Elias RA, Santos-Silva AR, Vargas PA, Lopes MA. Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients. Med Oral Patol Oral Cir Bucal. 2018;23:e180-e7. |
PMid:29476682 PMCid:PMC5911356 |
10. Dilsiz A, Aydin T, Gursan N. Capillary hemangioma as a rare benign tumor of the oral cavity: a case report. Cases Journal. 2009;2:8622-8. |
PMid:20181211 PMCid:PMC2827094 |
11. Reddy KS, Priyadarshini BS, Sree PK. Intralesional sclerotherapy - A novel approach for the treatment of intraoral haemangiomas. J Clin Diagn Res. 2016;10:ZD13-4. |
PMid:26894188 PMCid:PMC4740717 |
12. Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck. J Neurointerv Surg. 2014;6:695-8. |
PMid:24235099 |
13. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plastic Reconstr Surg. 1982;69:412-22. |
PMid:7063565 |
14. Brahmbhatt AN, Skalski KA, Bhatt AA. Vascular lesions of the head and neck: an update on classification and imaging review. Insights Imaging. 2020;11:19. |
PMid:32034537 PMCid:PMC7007481 |
15. Bonan PR, Miranda Lde P, Mendes DC, de Paula AM, Pego SP, Martelli-Júnior H. Effectiveness of low flow lesions sclerosis with monoethanolamine: Report of six cases. Med Oral Patol Oral Cir Bucal. 2007;12:524-7. |
PMid:17978777 |
16. Minkow B, Laufer D, Gutman D. Treatment of oral hemangiomas with local sclerosing agents. Int J Oral Surg. 1979;8:18-21. |
PMid:107130 |
17. Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: A descriptive study of 83 cases. Pediatr Surg Int. 2011;27:527-31. |
PMid:21290138 |
18. Ribeiro MC, de Mattos Camargo Grossmann S, do Amaral MBF, de Castro WH, Navarro TP, Procopio RJ, et al. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series. Int J Oral Maxillofac Surg. 2018;47:900-7. |
PMid:29329829 |
19. Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol. 2008;84:900-14. |
PMid:18596135 PMCid:PMC2538592 |
20. Candore G, Caruso C, Jirillo E, Magrone T, Vasto S. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for antiageing strategies and successful ageing achievement. Current Pharmaceutical Design. 2010;16:584-96. |
PMid:20388068 |
21. Machado MC, Coelho AM, Carneiro D'Albuquerque LA, Jancar S. Effect of ageing on systemic inflammatory response in acute pancreatitis. Int J Inflam. 2012;2012:270319. |
PMid:22292125 PMCid:PMC3265080 |
22. Muto T, Kinehara M, Takahara M, Sato K. Therapeutic embolization of oral hemangiomas with absolute ethanol. J Oral Maxillofacial Surg. 1990;48:85-8. |
PMid:2294216 |
23. Van Doorne L, Maeseneer MD, Stricker C, Vanrensbergen R, Stricker M. Diagnosis and treatment of vascular lesions of the lip. Br J Oral Maxillofacial Surg. 2002;40:497-503. |
PMid:12464208 |
24. Correa PH, Nunes LCC, Johann ACBR, Aguiar MCF, Gomez RS, Mesquita RA. Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res. 2007;21:40-5. |
PMid:17384854 |
25. Yan Y, Sun M, Hou R, Yan Z, Wang L, Cheng X, et al. Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region. J Oral Maxillofacial Surg. 2008;66:2219-25. |
PMid:18940483 |
26. Hanemann JA, Oliveira DT, Gomes MF, dos Anjos MJ, Sant'ana E. Congenital double lip associated to hemangiomas: report of a case. Med Oral. 2004;9:156-8. |
PMid:14990882 |